Analyst Consensus ?
ConsensusBuy38 ratings
Bullish3079.0%
Neutral718.4%
Bearish12.6%
FN2 Earnings Intelligence
Citizens Financial Group, Inc. analyst ratings
Citizens Financial Group, Inc. (CFG) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$70.97Current
$33Low
$61.08Average
$90High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 21, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 20, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 17, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Jul 17, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 17, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jul 17, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 17, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 17, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 16, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 15, 2026 |
| UBS | Buy | Buy | Maintain | Jul 7, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 29, 2026 |
| Argus Research | Buy | Buy | Maintain | Jan 23, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jan 22, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jan 22, 2026 |
| Raymond James | Outperform | Strong Buy | Downgrade | Jan 7, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 17, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 17, 2025 |
| Compass Point | Buy | Buy | Maintain | Dec 10, 2024 |
| Wedbush | Neutral | Neutral | Maintain | Apr 18, 2024 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Oct 23, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jul 20, 2023 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 12, 2022 |
| Citi | Sell | Neutral | Downgrade | Oct 8, 2019 |
| Argus | Buy | Hold | Upgrade | Jul 29, 2019 |
| Macquarie | Outperform | Neutral | Upgrade | Nov 27, 2018 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 22, 2018 |
| Bank of America | Buy | Underperform | Upgrade | Oct 22, 2018 |
| Sandler O'Neill | Buy | Hold | Upgrade | Apr 23, 2018 |
| Bernstein | Outperform | Market Perform | Upgrade | Sep 14, 2017 |
| PiperJaffray | Overweight | Neutral | Upgrade | Apr 21, 2017 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Nov 29, 2016 |
| Oppenheimer | Market Perform | Outperform | Downgrade | Nov 15, 2016 |
| Wells Fargo | Outperform | Market Perform | Upgrade | May 13, 2016 |
| Guggenheim | Buy | Neutral | Upgrade | Aug 26, 2015 |
| Evercore Partners | Buy | Buy | Maintain | Nov 3, 2014 |
Named analyst price targets
Upside is calculated against the persisted current price $70.97. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Argus Research | Kevin Heal | $80 | $72.57 | +12.7% | Jul 29, 2026 |
| Truist Financial | Analyst unavailable | $80 | $71.5 | +12.7% | Jul 21, 2026 |
| D.A. Davidson | Analyst unavailable | $85 | $74.4 | +19.8% | Jul 17, 2026 |
| Stephens | Matt Breese | $70 | $74.4 | -1.4% | Jul 17, 2026 |
| Robert W. Baird | Analyst unavailable | $75 | $74.4 | +5.7% | Jul 17, 2026 |
| Jefferies | Analyst unavailable | $90 | $74.1 | +26.8% | Jul 16, 2026 |
| Evercore ISI | John Pancari | $80 | $71.7 | +12.7% | Jul 6, 2026 |
| Robert W. Baird | Analyst unavailable | $72 | $70.98 | +1.5% | Jul 6, 2026 |
| Truist Financial | Analyst unavailable | $72 | $68.99 | +1.5% | Jun 24, 2026 |
| Evercore ISI | Analyst unavailable | $75 | $66.47 | +5.7% | Apr 21, 2026 |
| D.A. Davidson | Analyst unavailable | $74 | $64.45 | +4.3% | Apr 20, 2026 |
| RBC Capital | Gerard Cassidy | $70 | $64.97 | -1.4% | Apr 17, 2026 |
| Robert W. Baird | Analyst unavailable | $65 | $58.31 | -8.4% | Mar 9, 2026 |
| Evercore ISI | John Pancari | $77 | $66.51 | +8.5% | Feb 5, 2026 |
| Truist Financial | Analyst unavailable | $71 | $62.62 | +0.0% | Jan 26, 2026 |
| Argus Research | Kevin Heal | $72 | $63.64 | +1.5% | Jan 23, 2026 |
| New Street | Analyst unavailable | $73 | $65.43 | +2.9% | Jan 22, 2026 |
| RBC Capital | Analyst unavailable | $67 | $65.07 | -5.6% | Jan 22, 2026 |
| Morgan Stanley | Analyst unavailable | $73 | $64.06 | +2.9% | Jan 22, 2026 |
| Jefferies | David Chiaverini | $80 | $64.06 | +12.7% | Jan 21, 2026 |
| Raymond James | David Long | $66 | $62.14 | -7.0% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $69 | $61.2 | -2.8% | Jan 6, 2026 |
| Goldman Sachs | Ryan Nash | $73 | $61.23 | +2.9% | Jan 6, 2026 |
| Barclays | Jason Goldberg | $77 | $59.39 | +8.5% | Jan 5, 2026 |
| Truist Financial | Analyst unavailable | $63 | $59.59 | -11.2% | Dec 22, 2025 |
| Robert W. Baird | Analyst unavailable | $60 | $58.46 | -15.5% | Dec 11, 2025 |
| Truist Financial | Analyst unavailable | $56 | $48.39 | -21.1% | Oct 17, 2025 |
| Stephens | Q3 EPS | $60 | $50.64 | -15.5% | Oct 16, 2025 |
| UBS | Analyst unavailable | $62 | $53.16 | -12.6% | Oct 7, 2025 |
| Raymond James | Analyst unavailable | $62 | $54 | -12.6% | Oct 7, 2025 |
| Truist Financial | Brian Foran | $58 | $52.98 | -18.3% | Oct 3, 2025 |
| Evercore ISI | Analyst unavailable | $61 | $53.65 | -14.0% | Sep 30, 2025 |
| Morgan Stanley | Manan Gosalia | $71 | $53.38 | +0.0% | Sep 29, 2025 |
| Evercore ISI | Analyst unavailable | $57 | $52.27 | -19.7% | Sep 17, 2025 |
| Wells Fargo | Analyst unavailable | $57 | $47.03 | -19.7% | Jul 2, 2025 |
| Argus Research | Kevin Heal | $45 | $36.95 | -36.6% | Apr 24, 2025 |
| Truist Financial | Analyst unavailable | $51 | $41.19 | -28.1% | Mar 21, 2025 |
| Raymond James | David Long | $58 | $44.7 | -18.3% | Jan 21, 2025 |
| D.A. Davidson | Peter Winter | $48 | $42 | -32.4% | Oct 17, 2024 |
| RBC Capital | Gerard Cassidy | $45 | $42.41 | -36.6% | Oct 17, 2024 |
| Citigroup | Keith Horowitz | $50 | $42.41 | -29.5% | Oct 17, 2024 |
| Evercore ISI | John Pancari | $46 | $39.92 | -35.2% | Oct 2, 2024 |
| Morgan Stanley | Manan Gosalia | $50 | $39.2 | -29.5% | Aug 5, 2024 |
| Piper Sandler | Scott Siefers | $48 | $43.5 | -32.4% | Jul 26, 2024 |
| Morgan Stanley | Manan Gosalia | $41 | $40.92 | -42.2% | Jul 17, 2024 |
| Piper Sandler | Scott Siefers | $41 | $35.15 | -42.2% | Apr 26, 2024 |
| Wedbush | David Chiaverini | $35 | $33.05 | -50.7% | Apr 18, 2024 |
| UBS | Erika Najarian | $40 | $35.12 | -43.6% | Apr 4, 2024 |
| Morgan Stanley | Betsy Graseck | $33 | $26.96 | -53.5% | Aug 25, 2023 |
| Robert W. Baird | David George | $44 | $27.97 | -38.0% | May 23, 2023 |
| Barclays | Analyst unavailable | $57 | $39.37 | -19.7% | Jan 3, 2023 |
| D.A. Davidson | Analyst unavailable | $47 | $38.64 | -33.8% | Dec 21, 2022 |
| Morgan Stanley | Analyst unavailable | $53 | $41.7 | -25.3% | Dec 5, 2022 |
| Goldman Sachs | Analyst unavailable | $41 | $34.45 | -42.2% | Oct 3, 2022 |
| Deutsche Bank | Analyst unavailable | $50 | $39.12 | -29.5% | Sep 12, 2022 |
| Barclays | Jason Goldberg | $54 | $37.97 | -23.9% | Jul 31, 2022 |
| RBC Capital | Analyst unavailable | $55 | $36.27 | -22.5% | Jul 7, 2022 |
| Stephens | Analyst unavailable | $48 | $35.83 | -32.4% | Jun 13, 2022 |
| Goldman Sachs | Analyst unavailable | $49 | $40.87 | -31.0% | May 31, 2022 |
| Wolfe Research | Analyst unavailable | $33 | $39.6 | -53.5% | May 26, 2022 |
| Deutsche Bank | Matt O'Connor | $56 | $51.7 | -21.1% | Jan 28, 2022 |
| Credit Suisse | Susan Roth Katzke | $50 | $50.72 | -29.5% | Jan 24, 2022 |
| Citigroup | Jill Shea | $65 | $55.21 | -8.4% | Jan 12, 2022 |
| Barclays | Jason Goldberg | $62 | $48.77 | -12.6% | Jan 3, 2022 |
| Bank of America Securities | Ebrahim Poonawala | $52 | $42.92 | -26.7% | Jul 21, 2021 |
| Evercore ISI | John Pancari | $50 | $48.68 | -29.5% | May 28, 2021 |
| Piper Sandler | Kevin Barker | $54 | $48.86 | -23.9% | May 27, 2021 |
| Compass Point | Dave Rochester | $55 | $48.42 | -22.5% | May 18, 2021 |
| Argus Research | Kevin Heal | $50 | $43.15 | -29.5% | Apr 19, 2021 |
Track every rating change on CFG the moment it posts. Free to start.
Start free